Status:
COMPLETED
Synovial Chondrosarcoma: a Single Institution Experience
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Synovial Chondrosarcoma
Eligibility:
All Genders
18+ years
Brief Summary
single institution cases series review of histological, radiological and clinical data
Detailed Description
single institution cases series review of histological, radiological and clinical data. Investigators will retrieve from the archives of the Rizzoli institute all the cases with a histological diagnos...
Eligibility Criteria
Inclusion
- Male and female patients treated at Rizzoli Institute from 01 January 1982 to 31 December 2017
- Diagnosis of synovial chondrosarcoma
- Age ≥ 18 years
- Histological slides / formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis
- Written informed consent prior to any study-specific analysis and/or data collection
Exclusion
- Patients with histological diagnosis different from synovial chondrosarcoma
Key Trial Info
Start Date :
August 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03776942
Start Date
August 7 2018
End Date
August 31 2019
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCC Rizzoli Orthopedic Institute
Bologna, Italy, 40136